Retraction: NF-κB inhibitors attenuate MCAO induced neurodegeneration and oxidative stress—A reprofiling approach

, Frontiers Editorial Office

doi:10.3389/fnmol.2023.1275831

RETRACTION article

Front. Mol. Neurosci., 21 August 2023

Sec. Molecular Signalling and Pathways

Volume 16 - 2023 | https://doi.org/10.3389/fnmol.2023.1275831

Retraction: NF-κB inhibitors attenuate MCAO induced neurodegeneration and oxidative stress—A reprofiling approach

This article is a retraction of:

RETRACTED: NF-κB Inhibitors Attenuate MCAO Induced Neurodegeneration and Oxidative Stress—A Reprofiling Approach
1. Read original article

$\r\nFrontiers Editorial Office$ Frontiers Editorial Office^*

A Retraction of the Original Research Article
NF-κB inhibitors attenuate MCAO induced neurodegeneration and oxidative stress—A reprofiling approach

by Ali, A., Shah, F. A., Zeb, A., Malik, I., Alvi, A. M., Alkury, L. T., Rashid, S., Hussain, I., Ullah, N., Khan, A. U., and Koh, P. O. (2020). Front. Molec. Neurosci. 13:33. doi: 10.3389/fnmol.2020.00033

The journal retracts the 24 March 2020 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures, with areas of image duplication and manipulation in Figures 5, 6. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers' policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.

This retraction was approved by the Chief Editors of Frontiers in Molecular Neuroscience and the Chief Executive Editor of Frontiers. The authors did not agree to this retraction.

Citation: Frontiers Editorial Office (2023) Retraction: NF-κB inhibitors attenuate MCAO induced neurodegeneration and oxidative stress—A reprofiling approach. Front. Mol. Neurosci. 16:1275831. doi: 10.3389/fnmol.2023.1275831

Received: 10 August 2023; Accepted: 11 August 2023;
Published: 21 August 2023.

Approved by:

Jean-Marc Taymans, Institut National de la Santé et de la Recherche Médicale (INSERM), France

Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.